300143 Stock Overview
Focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
INKON Life Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.73 |
| 52 Week High | CN¥11.39 |
| 52 Week Low | CN¥6.51 |
| Beta | 0.91 |
| 11 Month Change | -3.66% |
| 3 Month Change | 36.66% |
| 1 Year Change | -7.86% |
| 33 Year Change | -40.63% |
| 5 Year Change | 15.56% |
| Change since IPO | 8.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300143 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -1.1% | -2.0% | -2.1% |
| 1Y | -7.9% | -17.0% | 2.8% |
Return vs Industry: 300143 exceeded the CN Healthcare industry which returned -17% over the past year.
Return vs Market: 300143 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 300143 volatility | |
|---|---|
| 300143 Average Weekly Movement | 11.6% |
| Healthcare Industry Average Movement | 8.7% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300143's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300143's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 2,268 | Wen Peng | www.300143.net |
INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. The company engages in the research, development, innovation, and services of scenarios and equipment medical devices. The company was formerly known as Starmap Medicine and Technology Co., Ltd.
INKON Life Technology Co., Ltd. Fundamentals Summary
| 300143 fundamental statistics | |
|---|---|
| Market cap | CN¥6.16b |
| Earnings (TTM) | CN¥88.93m |
| Revenue (TTM) | CN¥1.60b |
69.3x
P/E Ratio3.9x
P/S RatioIs 300143 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300143 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.60b |
| Cost of Revenue | CN¥1.19b |
| Gross Profit | CN¥407.66m |
| Other Expenses | CN¥318.73m |
| Earnings | CN¥88.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.14 |
| Gross Margin | 25.56% |
| Net Profit Margin | 5.58% |
| Debt/Equity Ratio | 21.9% |
How did 300143 perform over the long term?
See historical performance and comparison